To determine the association of clinicopathological characteristics with KRT80 expression, immunohistochemistry (IHC) analysis was performed using a tissue microarray (TMA) containing 120 primary CRC samples and paired adjacent normal mucosae. This evidence concerns the gene KRT80 and colorectal carcinoma.